4506.T
4506.T
JP3495000006
SUMITOMO PHARMA CO LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 453.294.000.000 398.832.000.000
13.7%
Cost of Revenue 196.401.000.000 153.437.000.000
28.0%
Gross Profit 256.893.000.000 245.395.000.000
4.7%
151.840.000.000 215.686.000.000
29.6%
Operating Income 105.053.000.000 29.709.000.000
253.6%
Pretax Income 100.344.000.000 17.611.000.000
469.8%
Net Income Common Stockholders 106.865.000.000 23.634.000.000
352.2%
-- --
--
-- --
--
ende